LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Mapping Technique Reveals Organization of Neuron Networks

By LabMedica International staff writers
Posted on 10 May 2015
Image: Researchers have developed a method to map the circuitry of the brain with a “neuronal positioning system” (NPS) (Photo courtesy of The Hebrew University of Jerusalem).
Image: Researchers have developed a method to map the circuitry of the brain with a “neuronal positioning system” (NPS) (Photo courtesy of The Hebrew University of Jerusalem).
A new technique permits neuroscience researchers to map the location of the axonal branches (arbors) of many individual neurons in the same tissue simultaneously.

Investigators at The Hebrew University of Jerusalem (Israel) and Harvard University (Cambridge, MA, USA) have significantly improved the retrograde tracer method for identifying axon location.

Retrograde tracing is a research method which is used in neuroscience to trace neural connections from their point of termination (the synapse) to their source (the cell body). The opposite technique is called anterograde tracing and is used to trace neural connections from their source to their point of termination (i.e. from cell body to synapse). Both the anterograde and retrograde tracing techniques are based on the visualization of the biological process of axonal transport. The anterograde and retrograde tracing techniques allow the detailed assessment of neuronal connections from a single population of neurons to their various targets throughout the nervous system. These techniques allow the "mapping" of connections between neurons in a particular structure (e.g., the eye) and the target neurons in the brain.

The investigators reported in the April 27, 2015, online edition of the journal Nature Methods that they had developed a method—a "neuronal positioning system" or NPS—to map the location of axonal arbors of many individual neurons simultaneously via the spectral properties of retrogradely transported dye-labeled vesicles.

To perform this technique, the investigators injected overlapping regions of an axon target area with three or more different colored retrograde tracers. The combinations and intensities of the colors in the individual vesicles depended on how far they were transported into the portion of the nerve cell that contained the nucleus but did not incorporate the dendrites or axon. The data obtained enabled the investigators to calculate the projection sites of each neuron's axon.

Contributing author Dr. Alex Binshtok, professor of medical neurobiology at The Hebrew University of Jerusalem, said, “The new method that we developed allows us to answer a "big question" in neuroscience about the organizational principles of neuronal circuits. Using the NPS technique that maps many axons in same tissue, we now can study what defines the routes along which the neurons will send their projections, as well as their targets. We can also learn how the wiring of the neuronal circuits changes during development and in a variety of pathological conditions. The answers to these questions will be the first step to comprehending how the information flows and is processed in the nervous system, and how changes in the neuronal organization affect neuronal function. I believe many scientists will find the NPS approach useful to help them answer the question of how the brain works.”

Related Links:

The Hebrew University of Jerusalem
Harvard University 


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Hemodynamic System Monitor
OptoMonitor

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more